Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region
Fecha de publicación: 3 de setiembre de 2020
Autores: Eleonora Del Prete, Alessio Francesconi, Giovanni Palermo, Sonia Mazzucchi, Daniela Frosini, Riccardo Morganti, Piero Coleschi, Laura Maria Raglione, Paola Vanni, Silvia Ramat, Alessio Novelli, Alessandro Napolitano, Carla Battisti, Martina Giuntini, Carlo Rossi, Chiara Menichetti, Monica Ulivelli, Valentino De Franco, Simone Rossi, Ubaldo Bonuccelli, Roberto Ceravolo & Tuscany Parkinson COVID-19 Participants
Background: If Parkinson’s Disease (PD) may represent a risk factor for Coronavirus disease 2019 (COVID-19) is debated and there are few data on the direct and indirect effects of this pandemic in PD patients. Objective: In the current study we evaluated the prevalence, mortality and case-fatality of COVID-19 in a PD cohort, also exploring possible risk factors. We also aimed to investigate the effect of lockdown on motor/non-motor symptoms in PD patients as well as their acceptability/accessibility to telemedicine.